FDA Anti-Infectives Cmte. To Consider Primary S. Aureus Bacteremia Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA seeks the committee’s input on whether primary bacteremia due to Staphylococcus aureus should be designated as a separate indication in light of obstacles encountered by sponsors in studying catheter-related blood stream infections.